Dina H Griauzde, MD, MSc, DABOM

 portrait of Dina H. Griauzde
Assistant Professor of Internal Medicine
Program Director, Caswell Diabetes Institute
Medical School
University of Michigan
North Campus Research Complex
2800 Plymouth Road, B16-371C
Ann Arbor, MI 48109
[email protected]
Available to mentor
Dina H Griauzde, MD, MSc, DABOM
portrait of Dina H. Griauzde
Assistant Professor
  • About
  • Center Memberships
  • Research Overview
  • Recent Publications

  • Manage Your Profile

    • About

    Assistant Professor in Internal Medicine and Research Scientist, Center for Clinical Management Research, Ann Arbor VA

    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Eisenberg Family Depression Center
    • Center Member
      Institute for Healthcare Policy and Innovation

    Research Overview

    Designing and testing novel interventions for type 2 diabetes prevention
    Developing, testing, and scaling innovative strategies for primary care-based obesity management

    Recent Publications

     See All Publications
    • Proceeding / Abstract / Poster
      A Low-Carbohydrate vs. Standard Diet Diabetes Prevention Program for Prediabetes: A Randomized Trial
      Griauzde D. 2026 Nov 2;
    • Proceeding / Abstract / Poster
      Implementation Of An Automated, Electronic Health Record Program To Support Very Low carbohydrate Nutrition Counseling
      Griauzde D, Marras M, Turner CD, Carter EW, Lee J, Segar M, Hisamatsu R. 2026 Jun 21;
    • Proceeding / Abstract / Poster
      Uncovering Racial and Ethnic Disparities in Referral to Weight Management Treatments
      Griauzde D, Turner CD, Hawkins J, Henderson J, Krumm A, Azeeza Z, Elrashid A, Ashebo L, Kilbourne AM, Piatt G. 2026 Jun 21;
    • Journal Article
      Mo1317 DETECTION OF CFDNA SHEDDING FROM ADVANCED PRECANCEROUS LESIONS
      Lu F, Cerna L, Alexander S, Tbeileh N, Atolia E, Gavino D, Hafez D, Kirkizlar E, Rabinowitz M, Aleshin A, Kawli T. Gastrointestinal Endoscopy, 2026 May 6; 103 (5): s - 302. DOI:10.1016/s0016-5107(26)00987-9
    • Journal Article
      Mo1317 DETECTION OF CFDNA SHEDDING FROM ADVANCED PRECANCEROUS LESIONS
      Lu F, Cerna L, Alexander S, Tbeileh N, Atolia E, Gavino D, Hafez D, Kirkizlar E, Rabinowitz M, Aleshin A, Kawli T. Gastroenterology, 2026 May 3; 170 (6): s - 302. DOI:10.1016/s0016-5085(26)01056-5
    • Journal Article
      Abstract 112: Analytical performance of an enhanced variant (EV) pipeline for improved circulating tumor DNA (ctDNA) detection in samples with low tumor burden.
      Hafez D, Dong B, Shahpurwalla A, Sridhar B, Hsieh A, Feeney J, Ngo V, Tbeileh N, Aleshin A, Rabinowitz M, Sethi H, Hou C, Ptashkin R, Kirkizlar E, Zehir A. Cancer Research, 2026 Apr 5; 86 (7_Supplement): 112 - 112. DOI:10.1158/1538-7445.am2026-112
    • Journal Article
      Abstract 113: Assessment of sequencing error rates in healthy plasma samples across two whole genome sequencing platforms.
      Shahpurwalla A, Montague Z, Lu F, Alexander S, Goyal G, Hafez D, Rabinowitz M, Kirkizlar E, Zehir A. Cancer Research, 2026 Apr 5; 86 (7_Supplement): 113 - 113. DOI:10.1158/1538-7445.am2026-113
    • Journal Article
      Abstract 3856: Detection of cfDNA shedding from advanced precancerous lesions.
      Lu F, Cerna L, Alexander S, Tbeileh N, Atolia E, Hafez D, Kirkizlar E, Rabinowitz M, Aleshin A, Kawli. T. Cancer Research, 2026 Apr 5; 86 (7_Supplement): 3856 - 3856. DOI:10.1158/1538-7445.am2026-3856

    Featured News & Stories

         2025 Dean's Lecture and Bold Science Symposium
    Medical School News

    2025 Dean’s Lecturer: GLP-1 therapies saving, improving lives of many patients

    Lives are being saved, and many others are being changed dramatically, by current GLP-1 therapies like tirzepatide, which has helped many patients treat type 2 diabetes and sleep apnea, and also lose weight. It has been a long road from bench research to clinical trials to the health care market, but patients are now benefitting more than ever, according to a leading scientist who served as the keynote speaker for the second annual Dean’s Lecture and Bold Science Symposium, “Metabolism Research from Bench to Bedside.” Daniel Skovronsky, M.D., Ph.D., chief scientific officer and executive vice president of science and technology at Eli Lilly and Company and president of Research Laboratories and Lilly Immunology, was the Dean’s Lecturer on April 14 at the North Campus Research Complex Dining Hall.
         yellow background blue pills floating around and medicine shots
    Health Lab

    Most older adults want insurance to cover obesity drugs and many want to use them

    Medicare and most private insurance plans don’t cover anti-obesity medications like Wegovy (also sold as Ozempic), but a new poll of older adults shows widespread support and interest in using them.